SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-23-043724
Filing Date
2023-07-28
Accepted
2023-07-28 18:33:18
Documents
2
Period of Report
2023-07-28

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 8340
2 POA DOCUMENT poa.txt EX-24 3689
  Complete submission text file 0001209191-23-043724.txt   13490
Mailing Address ONE COMMERCE SQUARE 2005 MARKET STREET, 39TH FLOOR PHILADELPHIA PA 19103
Business Address ONE COMMERCE SQUARE 2005 MARKET STREET, 39TH FLOOR PHILADELPHIA PA 19103 2678660312
Passage BIO, Inc. (Issuer) CIK: 0001787297 (see all company filings)

IRS No.: 822729751 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O PASSAGE BIO, INC. 2005 MARKET STREET, 39TH FLOOR PHILADELPHIA PA 19103
Business Address
Borthwick Kathleen (Reporting) CIK: 0001987062 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39231 | Film No.: 231124562